BACKGROUND: To determine at what stage during gastric carcinogenesis Epstein-Barr virus (EBV) enters the gastric epithelial cells, the presence of EBV was investigated in two pathogenetically related but distinct forms of adenocarcinoma of the stomach-gastric carcinoma of the intact stomach (GCIS) and gastric stump carcinoma (GSC)-and their presumed precursor lesions. PATIENTS AND METHODS: Eleven patients with EBV positive GCIS and eight patients with EBV positive GSC, demonstrated by the highly sensitive EBV encoded RNA 1/2 (EBER1/2) RNA in situ hybridisation (RISH) technique, were studied. Paraffin wax embedded tissue available from preoperative gastric biopsies and tumour adjacent tissue from the resection specimens containing normal gastric mucosa, inflamed gastric mucosa, and preneoplastic lesions (intestinal metaplasia and dysplasia) was investigated by EBER1/2 RISH, in addition to EBV nuclear antigen 1 (EBNA-1) and latent membrane protein 1 (LMP-1) immunohistochemistry (IHC). RESULTS: In both GCIS and GSC and their precursor lesions EBER1/2 transcripts were restricted to the carcinoma cells. In addition, positivity of EBNA-1 IHC was also restricted to the tumour cells. IHC for LMP-1 was negative in all cases tested. CONCLUSIONS: The absence of EBER1/2 transcripts in preneoplastic gastric lesions (intestinal metaplasia and dysplasia) and their presence in two distinct types of gastric carcinoma strongly suggest that EBV can only infect neoplastic gastric cells and thus is a late event in gastric carcinogenesis.
BACKGROUND: To determine at what stage during gastric carcinogenesis Epstein-Barr virus (EBV) enters the gastric epithelial cells, the presence of EBV was investigated in two pathogenetically related but distinct forms of adenocarcinoma of the stomach-gastric carcinoma of the intact stomach (GCIS) and gastric stump carcinoma (GSC)-and their presumed precursor lesions. PATIENTS AND METHODS: Eleven patients with EBV positive GCIS and eight patients with EBV positive GSC, demonstrated by the highly sensitive EBV encoded RNA 1/2 (EBER1/2) RNA in situ hybridisation (RISH) technique, were studied. Paraffin wax embedded tissue available from preoperative gastric biopsies and tumour adjacent tissue from the resection specimens containing normal gastric mucosa, inflamed gastric mucosa, and preneoplastic lesions (intestinal metaplasia and dysplasia) was investigated by EBER1/2 RISH, in addition to EBV nuclear antigen 1 (EBNA-1) and latent membrane protein 1 (LMP-1) immunohistochemistry (IHC). RESULTS: In both GCIS and GSC and their precursor lesions EBER1/2 transcripts were restricted to the carcinoma cells. In addition, positivity of EBNA-1 IHC was also restricted to the tumour cells. IHC for LMP-1 was negative in all cases tested. CONCLUSIONS: The absence of EBER1/2 transcripts in preneoplastic gastric lesions (intestinal metaplasia and dysplasia) and their presence in two distinct types of gastric carcinoma strongly suggest that EBV can only infect neoplastic gastric cells and thus is a late event in gastric carcinogenesis.
Authors: I Cruz; A J Van Den Brule; A A Brink; P J Snijders; J M Walboomers; I Van Der Waal; C J Meijer Journal: Int J Cancer Date: 2000-05-01 Impact factor: 7.396
Authors: Jaap M Middeldorp; Antoinette A T P Brink; Adriaan J C van den Brule; Chris J L M Meijer Journal: Crit Rev Oncol Hematol Date: 2003-01 Impact factor: 6.312
Authors: A zur Hausen; N C van Grieken; G A Meijer; M A Hermsen; E Bloemena; S G Meuwissen; J P Baak; C J Meijer; E J Kuipers; A J van den Brule Journal: Gastroenterology Date: 2001-09 Impact factor: 22.682
Authors: H Yanai; T Murakami; H Yoshiyama; H Takeuchi; J Nishikawa; H Nakamura; K Okita; O Miura; N Shimizu; K Takada Journal: J Clin Gastroenterol Date: 1999-07 Impact factor: 3.062
Authors: Josine van Beek; Axel zur Hausen; Elma Klein Kranenbarg; Cornelis J H van de Velde; Jaap M Middeldorp; Adriaan J C van den Brule; Chris J L M Meijer; Elisabeth Bloemena Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Maria D Begnami; Andre L Montagnini; Andre L Vettore; Sueli Nonogaki; Mariana Brait; Alex Y Simoes-Sato; Andrea Q A Seixas; Fernando A Soares Journal: World J Gastroenterol Date: 2006-08-21 Impact factor: 5.742
Authors: Julie L Ryan; You-Jun Shen; Douglas R Morgan; Leigh B Thorne; Shannon C Kenney; Ricardo L Dominguez; Margaret L Gulley Journal: Dig Dis Sci Date: 2012-03-13 Impact factor: 3.199
Authors: M Constanza Camargo; Kyoung-Mee Kim; Keitaro Matsuo; Javier Torres; Linda M Liao; Douglas R Morgan; Angelika Michel; Tim Waterboer; Jovanny Zabaleta; Ricardo L Dominguez; Yasushi Yatabe; Sung Kim; Erick R Rocha-Guevara; Jolanta Lissowska; Michael Pawlita; Charles S Rabkin Journal: Helicobacter Date: 2015-08-07 Impact factor: 5.753
Authors: Camtu D Truong; Wei Feng; Wei Li; T Khoury; Q Li; S Alrawi; Yingyan Yu; Keping Xie; James Yao; Dongfeng Tan Journal: J Exp Clin Cancer Res Date: 2009-02-03